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ABSTRACT:  Data obtained with in vitro fecal incubations and a feeding study indicate black tea 19 
theaflavin and its galloyl derivatives are not absorbed in detectable amounts in either the upper or 20 
the lower gastrointestinal tract. The theaflavin skeleton is comparatively resistant to degradation by 21 
colonic bacteria with a 67% recovery being obtained after a 24 h incubation which yielded 21 22 
phenolic and aromatic catabolites. The theaflavin galloyl moiety was removed by the microbiota and 23 
the released gallic acid further transformed to 3-O-and 4-O-methyl gallic acids, pyrogallol-1-sulfate 24 
and pyrogallol-2-sulfate, which were excreted in urine in amounts equivalent to 94% of intake. The 25 
main urinary product potentially derived from breakdown of the theaflavin skeleton was 26 
3-(4′-hydroxyphenyl)propionic acid. A number of the colonic catabolites originating from gallic acid 27 
and theaflavins have been reported to be bioactive in ex vivo and in vitro models with a variety of 28 
potential modes of action. 29 
 30 
KEYWORDS: black tea theaflavins, bioavailability, colonic catabolism, phenolic catabolites, 31 
HPLC-HRMS 32 
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INTRODUCTION 33 
Camellia sinensis-based teas, are widely consumed throughout the world,1 and contain an array of 34 
flavan-3-ols and derived compounds.2 Green teas are a rich mixture of flavan-3-ol monomers 35 
including (−)-epicatechin 1, (+)-gallocatechin-3-O-gallate 2, (−)-epicatechin-3-O-gallate 3 and 36 
(−)-epigallocatechin-3-O-gallate 4 (Figure 1). Black teas, produced by fermentation of green tea 37 
leaves, contain substantially reduced amounts of flavan-3-ol monomers as a result of polyphenol 38 
peroxidase- and oxidase-mediated conversion to theaflavins and more substantial amounts of 39 
thearubigins.2-4 Thearubigins are an extremely complex mixture of high molecular weight 40 
polymers5,6 while theaflavins are dimer-like structures in the form of theaflavin 5, 41 
theaflavin-3-O-gallate 6, theaflavin-3´-O-gallate 7 and theaflavin-3,3´-O-digallate 8 (Figure 1). These 42 
compounds are potential bioactive components in black tea, consumption of which has been linked 43 
to beneficial effects on health.7,8 Animal and in vitro models have demonstrated that theaflavins (i) 44 
inhibit pro-inflamatory cytokines including tumour necrosis factor (TNF)-α and interleukins (IL)-1β 45 
and IL-6,9 (ii) prevent of DNA damage in lymphocytes,10 (iii) supress the formation of reactive 46 
oxygen species by preserving the activities of antioxidant enzymes and (iv) inhibit the formation of 47 
thiobarbituric acid reactive substances and copper-induced lipid peroxidation of LDL and HDL.11   48 
Human clinical trials have shown that long-term regular consumption of black tea can improve 49 
cardiovascular function by lowering blood pressure,12 and reducing platelet activation and plasma 50 
C-reactive protein in healthy men.13 In addition, prospective studies have shown an association 51 
between black tea consumption and the incidence of different types of cancers.14-16  52 
However, there is very limited information about the potential protective effects of theaflavins 53 
and thearubigins in the large intestine, and the impact on health of any colonic microbiota-derived 54 
catabolites after they enter the bloodstream and are transported to other sites within the body.17 55 
Although consumed far more extensively in Europe and the United States than green tea, the 56 
absorption of (poly)phenols from black tea beverages of (poly)phenols, their human metabolism, 57 
and gut flora catabolism have received only limited attention. Such studies have focused on the 58 
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absorption of flavan-3-ol monomers18 and flavonol glycosides19,20 from black tea, with or without 59 
added milk which appeared to have relatively little effect. To date, there is one report on the 60 
absorption of trace amounts of theaflavins by humans equivalent to 0.001% of intake.21 More 61 
recently, two studies have shown the importance of the colonic microbiota in the metabolism of 62 
theaflavins by both mice and humans.22,23 The present study investigated metabolites and colonic 63 
catabolites excreted in urine after ingestion of 1 g of a theaflavin extract by two healthy volunteers. 64 
In addition, the theaflavin extract was incubated under anaerobic conditions with fresh human fecal 65 
samples from three donors. In both studies, identification and quantitation of theaflavins and their 66 
derived products used high-performance liquid chromatography-high resolution mass spectrometry 67 
(HPLC-HRMS).    68 
 69 
MATERIAL AND METHODS 70 
Chemicals and Reagents. Formic acid, 2´,4´,5´-trimethoxycinnamic acid, ethyl gallate, 71 
(−)-epicatechin, (+)-gallocatechin-3-O-gallate, (−)-epicatechin-3-O-gallate and 72 
(−)-epigallocatechin-3-O-gallate and the phenolics 4-hydroxybenzoic acid, 3-hydroxybenzoic acid, 73 
ferulic acid, isoferulic acid, 4´-hydroxyphenylacetic acid, 3´-hydroxyphenylacetic acid, 74 
3´-methoxy-4´-hydroxyphenylacetic acid (homovanillic acid), 3,4-dihydroxybenzoic acid 75 
(protocatechuic acid), 3-(3´-methoxy-4´-hydroxy)mandelic acid, 4´-hydroxymandelic acid, 76 
3-(3´,4´-dihydroxyphenyl)propionic acid (dihydrocaffeic acid), 3-(3´,4´-dihydroxyphenyl)acetic 77 
acid (homoprotocatechuic acid), 3-(4´- hydroxyphenyl)propionic acid, phenylacetic acid, 78 
1,3,5-trihydroxybenzene (phloroglucinol), 1,2,3-trihydroxybenzene (pyrogallol) and 79 
1,2-dihydroxybenzene (catechol) were purchased from Sigma-Aldrich (Poole, Dorset, UK). 80 
3´-Hydroxyhippuric and 3-O-methyl gallic acid were, respectively, purchased from Toronto 81 
Research Chemicals (Toronto, ON, Canada) and Extrasynthese (Genay, France). Caffeic 82 
acid-3´-sulfate, ferulic acid-4´-O-glucuronide, ferulic acid-4´-sulfate, 3-(4´- 83 
hydroxyphenyl)propionic acid-3'-O-glucuronide (dihydrocaffeic acid-3'-O-glucuronide), 84 
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3-(3´-hydroxyphenyl)propionic acid-4´-sulfate (dihydrocaffeic acid-4'-sulfate), 85 
3-(4´-hydroxyphenyl)propionic acid-3´-sulfate (dihydrocaffeic acid-3'-sulfate), 86 
3-(3´-methoxyphenyl)propionic acid-4´-O-glucuronide (dihydroferulic acid-4´-O-glucuronide) 87 
and 3-(3´-methoxyphenyl)propionic-acid-4´-sulfate (dihydroferulic acid-4´-sulfate) were kindly 88 
provided by Denis Barron (Nestle Research Center, Lausanne, Switzerland) and Gary Williamson 89 
(School of Food Science and Nutrition, University of Leeds, UK). 4′-Hydroxyhippuric acid was 90 
obtained from Bachem (UK) Ltd (St Helens, UK). Synthetic urine (Negative Urine Control) was 91 
purchased from Sigma-Aldrich, Madrid, Spain. 5-(3´,4´-Dihydroxyphenyl)-γ-valerolactone, 92 
5-(3´-hydroxyphenyl)-γ-valerolactone and 5-(phenyl)-γ-valerolactone-3´-O-sulfate were 93 
synthesized according to Curti et al.24 Reagents and chemicals used in the preparation of buffers 94 
employed in the fecal fermentation experiments were of analytical grade and purchased from 95 
Fisher Scientific (Loughborough, UK), Across Organics (Geel, Belgium), AnalaR (Pool, UK) and 96 
Sigma-Aldrich (Steinheim, Germany). HPLC-MS grade methanol and acetonitrile were obtained 97 
from Sigma-Aldrich (Steinheim, Germany).  98 
Theaflavin Extract. The theaflavin extract was prepared commercially from an aqueous 99 
extract of fermented green tea leaves which, after membrane filtration, was fractionated by column 100 
chromatography using a macroporous resin before being spray dried to form a powder. 101 
Human Feeding Study. Two healthy male volunteers between 29 and 33 years old with a BMI 102 
of 23.9 and 28.2 kg/m2 were recruited at the University of Glasgow. The volunteers, who were 103 
non-smokers and not receiving medication, were informed about the aim of the study and gave their 104 
written consent before their particpation in the trial. Volunteers followed a low-(poly)phenol diet 105 
for 60 h prior to the study and for 30 h after supplementation, avoiding fruits, vegetables, high-fibre 106 
products, and beverages such as tea, coffee, fruit juice, and wine. Before feeding, the subjects 107 
provided 0-30 h baseline urine over four time periods (0-4, 4-12, 12-24 and 24-30 h). On the day of 108 
the feeding, after an overnight fast, each subject ingested 1 g of encapsulated theaflavin powder. A 109 
light breakfast of white bread, cheese, ham and milk was provided 2 h after the theaflavin intake. 110 
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Following supplementation all urine was collected over four time periods (0-4, 4-12, 12-24 and 111 
24-30 h). The volume of urine excreted was measured and aliquots stored at -80 °C prior to 112 
HPLC-HRMS analysis. The study was approved by the University of Glasgow Royal Infirmary Ethics 113 
Committee. 114 
Processing of Urine. Urine samples were prepared as follows: 4 mL of urine was added to 2 mL 115 
of 1% aqueous formic acid containing 2.8 µg of ethyl gallate as an internal standard. 4 mL of urine 116 
was added to 2 mL of 1% aqueous formic acid containing 2.8 µg of ethyl gallate as an internal 117 
standard. Strata-X (33 µ, 500 mg) solid phase extraction cartridges (Phenomenex, Macclesfield, U.K.) 118 
were washed and activated with 6 mL of MeOH and conditioned with 6 mL of H2O/formic acid (99:1, 119 
v/v). The acidified urine was loaded onto the cartridge which was washed with 6 mL of H2O/formic 120 
acid (99:1, v/v) before being eluted with 6 mL of MeOH/formic acid (99:1, v/v). The eluate was 121 
reduced to dryness in vacuo in a Speed Vac protected from light at 35 °C and re-suspended in 50 µL 122 
of MeOH/formic acid (99:1, v/v) and 150 µL of deionized water.   123 
Fecal Sample Preparation. Fecal samples were obtained from three non-smoker volunteers 124 
(two female and one male, different individuals to those who participated in the feeding study), who 125 
had not consumed antibiotics for at least 3 months before the study. The volunteers followed a 126 
(poly)phenol-low diet for 48 h before fecal sample collection. The collection of the fecal samples and 127 
the preparation of the fecal slurries was carried out according to Roowi et al. 25 128 
Fermentation Medium and fecal incubation. Fermentation medium was prepared according 129 
to Roowi et al. 25 The fecal incubation used procedures described by Pereira-Caro et al. 26 The 130 
theaflavin extract was added to a final concentration of 10 µmol per 50 mL of incubation medium. 131 
Aliquots (5 mL) of fecal suspensions were taken after 0 h, 1 h, 2 h, 4 h, 6 h, 8 h, and 24 h and stored 132 
immediately at −80 °C. 133 
Extraction of Theaflavins from Fecal Incubates. Extraction of theaflavins from faecal 134 
incubates was adapted from Pereira-Caro et al.26 with some modifications. Briefly, 500 µL of 135 
defrosted fecal sample was spiked with 300 µg of 2´,4´,5´-trimethoxycinnamic acid, used as internal 136 
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standard. The supernatants obtained after three ethyl acetate extractions were reduced to dryness 137 
in vacuo and resuspended in 1 mL MeOH/water/formic acid (49.5:49.5:1, v/v/v). 138 
Analysis of Theaflavins and Their Metabolites in Urine and Fecal Samples. The theaflavin 139 
extract, SPE-concentrated urine samples and purified fecal samples were analysed using a Dionex 140 
Ultimate 3000 UHPLC system comprising of a UHPLC pump, a PDA detector scanning from 200 to 141 
600 nm, and an autosampler operating at 4° C (Thermo Scientific, San Jose, CA, USA). A 150 x 4.6 142 
mm i.d. 2.6 µm 100A XB-C18 Kinetex column (Phenomenex, Macclesfield, UK) was used for the 143 
analysis of the theaflavins, and a 150 x 4.6 mm i.d. 5 µm 100 A C18 Kinetex column (Phenomenex) 144 
for the analysis of the phenolic and aromatic catabolites, (−)-epicatechin metabolites and 145 
phenylvalerolactones and valeric acids. Both columns were maintained at 40 °C and eluted at a flow 146 
rate of 1.0 mL/min, with, respectively, a 70 min gradient of 5-40% acetonitrile in 0.1% aqueous 147 
formic acid, and a 42 min gradient of 3-50% methanol in 0.1% aqueous formic acid. After passing 148 
through the flow cell of the PDA detector the column eluate was split and 0.2 mL/min directed to an 149 
Exactive Orbitrap mass spectrometer (Thermo Scientific, San José, CA, USA) fitted with a heated 150 
electrospray ionization probe (HESI) operating in negative ionization mode. Full scans were 151 
recorded in a m/z range of 100-1800 with a resolution of 50.000 and with a full AGC target of 152 
1000000 charges, using 2 microscans. Analyses were also based on scans with in-source 153 
collision-induced dissociation at 25.0 eV. Two MS conditions with HESI in negative ionization mode 154 
were used: (i) capillary temperature was 300 °C, the heater temperature was 150 °C, the sheath gas 155 
was 60 units, the auxiliary gas was 20 units, and the spray voltage was 4.0 kv for the analysis of 156 
theaflavins; (ii) the capillary temperature was 275 °C, the heater temperature was 150 °C, the sheath 157 
gas was 20 units, the auxiliary gas was 16 units, and the spray voltage was 4.0 kv for the analysis of 158 
phenolic catabolites, epicatechin metabolites and phenylvalerolactones and valeric acids. Data 159 
acquisition and processing were carried out using Xcalibur 3.0 software (Thermo Scientific, San José, 160 
CA, USA). Before a measurement series, the Exactive Orbitrap was calibrated externally on a weekly 161 
basis using a ready-to-use calibration mixture (Pierce ESI Negative Ion Calibration Solution), 162 
Page 7 of 35
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
  
 
8
obtained from Thermo Scientific. Targeted identifications of theaflavins and their potential 163 
metabolites and catabolites were achieved by co-chromatography and comparing the exact mass 164 
with available standards. When standards were not available, compounds were tentatively identified 165 
by comparing the theoretical exact mass of the molecular ion with the measured accurate mass of 166 
the molecular ion. Identifications were categorized according to the Metabolite Standards Initiative 167 
Metabolite Identification (MSIMI) levels.27  168 
Theaflavins were quantified based on chromatographic 365 nm peak areas and expressed 169 
relative to standards of theaflavins. Quantification of metabolites and catabolites were carried out by 170 
selecting the theoretical exact mass of the molecular ion by reference to 0.05-150 ng standard 171 
curves. The linearity was determined for all the available standards. Limits of detection (LOD) and 172 
limits of quantification (LOQ) were estimated from the signal to noise ratio of each compound 173 
showing a signal-to-noise ratio ≥ 3 and ≥ 10, respectively. LOD and LOQ ranged from 0.03 to 0.1 ng 174 
and from 0.09 to 0.7 ng, respectively. The precision of the assay (the coefficient of intra-assay 175 
variation) was ranged from 1.1 to 5.2%. All reference compounds used for calibration curves were 176 
made up in synthetic urine and a blank fecal extract processed as described above. In absence of 177 
reference compounds, metabolites were quantified by reference to the calibration curve of a closely 178 
related parent compound. 179 
Statistical Analysis. Because of the sample size, Wilcoxon post-hoc signed-rank test was used 180 
to determine whether differences in total excretion of metabolites and phenolic catabolites after 181 
theaflavin intake. Significance was accepted at the P<0.05 level and data are presented as mean 182 
values ± SEM unless stated otherwise. All statistical analyses were performed using the Statistix 9.0 183 
software. 184 
 185 
RESULTS AND DISCUSSION 186 
Characterization of the Theaflavin Extract.  HPLC-HRMS analysis of the theaflavin extract 187 
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revealed the presence of four individual theaflavins. The quantities of each individual theaflavin, 188 
along with the small amounts of (−)-epicatechin 1, (+)-gallocatechin-3-O-gallate 2, 189 
(−)-epicatechin-3-O-gallate 3, (−)-epigallocatechin-3-O-gallate 4 and procyanidin dimer 190 
B2-3´-O-gallate 9 (Figure 1), which were present in 1 g of the extract are shown in Table 1. When 191 
consuming 1 g of the extract the volunteers ingested 177 µmol, 307 µmol, 172 µmol and 332 µmol of 192 
theaflavin 5, theaflavin-3-O-gallate 6, theaflavin-3’-O-gallate 7 and theaflavin-3,3’-O-digallate 8, 193 
respectively, a total of 988 µmol. The ingested 1014 µmol supplement, therefore, contained >97% 194 
theaflavins, together with 3.4 µmol of flavan-3-ol monomers and 22.7 µmol of procyanidin dimer 195 
B2-3´-O-gallate 9.  196 
Urinary Excretion of Theaflavins and Metabolites.  No theaflavins 5, theaflavin-3-O-gallate 197 
6, theaflavin-3’-O-gallate 7 or theaflavin-3,3’-O-digallate 8 or their phase II metabolites were 198 
detected in urine excreted 0-30 h after an intake of the 1 g theaflavin extract by the two volunteers.  199 
The four flavan-3-ols monomers (Table 1) were following ingestion, in part, be excreted in 200 
urine as glucuronide, sulfate and methylated metabolites, referred to as structurally-related 201 
epicatechin metabolites (SREMs).28 The 3.4 µmol of monomers, along with the 22.7 µmol of 202 
procyanidin dimer B2-3´-O-gallate 9 in the extract, also underwent undergo a partial conversion to 203 
5C-ring fission metabolites (5C-RFMs), the phenyl-γ-valerolactones and the 204 
phenyl-γ-hydroxyvaleric acids and their phase II metabolites28,29. No SREMs or 5C-RFMs were 205 
excreted in urine pre-supplementation and the amounts excreted over the 0-30 h collection period 206 
after acute ingestion of the theaflavin extract are presented in Table 2. Seven SREMs were detected 207 
in amounts ranging from 0.9 ± 0.2 nmol for an epicatechin-O-glucuronide to 43 ± 8 nmol for an 208 
O-methyl-(−)-epicatechin-O-glucuronide. Seventeen 5C-RFMs in the form of sulfates and 209 
glucuronide conjugates of phenyl-ɣ-valerolactones and phenyl-γ-hydroxyvaleric acids were 210 
identified and quantified. Overall 60 ± 15 nmol of SREMs were excreted along with 1437 ± 436 nmol 211 
of 5C-RFMs (Table 2)   212 
Urinary Phenolic and Aromatic Catabolites. HPLC-HRMS analysis revealed a total of 41 213 
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phenolic and aromatic compounds excreted in urine 0-30 h following an acute intake of 1 g of 214 
theaflavins (Table 3). Unlike the SREMs and 5C-RFMs, many of these compounds are produced in the 215 
body by pathways unrelated to (poly)phenol intake2. Hence, in order to assess the impact of 216 
theaflavin consumption, the quantitative data in Table 3 are adjusted values obtained by subtraction 217 
of the amount of phenolics excreted in the 30 h pre-supplementation period. Twenty one metabolites 218 
were excreted in significantly increased amounts. They were 3-(4′-hydroxyphenyl)propionic acid 10, 219 
3´,4´-dihydroxyphenylacetic acid 11, 3´-methoxy-4´-hydroxyphenylacetic acid 12, 220 
3´-hydroxyphenylacetic acid 13, 4´-hydroxyphenylacetic acid 14, phenylacetic acid 15, 221 
3,4-dihydroxybenzoic acid 16, 3-hydroxybenzoic acid 17, 4-hydroxybenzoic acid 18, benzoic 222 
acid-4-sulfate 19, 3-O-methylgallic acid 20, 4-O-methylgallic acid 21, gallic acid 22, phloroglucinol 223 
(1,3,5-trihydroxybenzene) 23, catechol (1,2-dihydroxybenzene) 24, pyrogallol 224 
(1,2,3-trihydroxybenzene) 25, pyrogallol-1-O-sulfate 26, pyrogallol-2-O-sulfate 27, 225 
pyrogallol-2-O-glucuronide 28, 3′-hydroxyhippuric acid 29 and 4′-hydroxyhippuric acid 30 (Figure 2). 226 
The main increase was in the excretion of hydroxybenzene derivatives (Table 3). Many of these 227 
compounds have previously been detected in urine after ingestion of black tea30-33. In total the 228 
increased excretion of the 21 catabolites was 955 ± 376 μmol equivalent to 94% of the 1014 μmol 229 
intake of polyphenolic compounds (Table 3)  230 
Theaflavin Degradation by Fecal Suspensions. Fecal samples from three donors, which 231 
HPLC-HRMS showed did not contain detectable quantities of theaflavins when voided, were 232 
incubated in vitro under anaerobic conditions with 10 µmol of the theaflavin extract for a period of 233 
24 h and aliquots taken over a range of time points were analyzed by HPLC-HRMS. Figure 3 234 
illustrates the levels of the four individual theaflavins in the incubates. With samples from 235 
volunteers 1 and 2 incubation led to an increase in theaflavin 5 and a concomitant decline in the 236 
levels of theaflavin-3-O-gallate 6, theaflavin-3’-O-gallate 7 and theaflavin-3,3’-O-digallate 8, a 237 
consequence of cleavage of the 3 and 3’-O-gallate moieties. These changes were less evident in 238 
incubations with feces from volunteers 3 seemingly as a consequence of reduce degalloylation by the 239 
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fecal bacteria of this donor. At the end of the 24 h incubation period the total theaflavins remaining, 240 
from the 10 µmol added at 0 h, were 7.5 µmol (volunteer 1), 6.7 µmol (volunteer 2) and 6.0 µmol 241 
(volunteer 3) (Table 4) giving an average value of 6.7 ± 0.4 µmol, corresponding to a 67% recovery.  242 
The quantities of phenolic catabolites formed during the incubation of the theaflavin extract 243 
with the fecal samples are also presented in Table 5. The values are corrected for baseline levels of 244 
benzoic acid, and 3-(phenyl)propionic and phenylacetic acids present in the control fecal media. The 245 
fermentations resulted in the appearance of relatively small amounts of 6 phenolic catabolites, with 246 
3-hydroxybenzoic acid 17, pyrogallol 25, and benzoic acid 31 as the major transformation products 247 
after 8 h and 24 h incubations in samples from donors 1 and 2. Low levels of gallic acid 22 were 248 
detected in the first 1 h of incubation of feces from two donors, the levels of which declined 249 
completely after 24 h of incubation (Table 5). This decline was accompanied by appearance of 250 
pyrogallol 25 in the 6-24 h of incubation. In addition, low levels of 3,4-dihydroxybenzoic acid 16 and 251 
3-(3,4´dihydroxyphenyl)propionic acid 32 were detected after 2, 4, 6 and 8 h although not in all 252 
samples from the 3 donors. Indeed, there were substantial differences in the catabolite profiles of 253 
the 3 donors, presumably due to inter-individual variations in the colonic microbiota. 254 
Other catabolites such as 5-(3´-hydroxyphenyl)-ɣ-hydroxyvaleric acid 33, 255 
5-(phenyl)-ɣ-hydroxyvaleric acid 34 and 5-(3´,4´-dihydroxyphenyl)- ɣ-valerolactone 35 accumulated 256 
in small amounts, while 5-(3´-hydroxyphenyl)-ɣ-valerolactone 36 appeared transitorily after 8 h of 257 
incubation (Table 5). These four 5C-RFMs are known colonic degradation products of flavan-3-ols 258 
monomers and possibly to some extent the procyanidin dimer28,29 a small quantity of which was 259 
present in the theaflavin extract (Table 1).  260 
  Although a preliminary study because of the limited number of volunteers involved, this 261 
detailed investigation none-the-less provided much novel information on the fate of black tea 262 
theaflavins following ingestion. Mulder et al.21 previously reported the presence of trace amounts of 263 
theaflavins in plasma and urine, corresponding to 0.0006% of intake after the ingestion of a 700 mg 264 
mixture of theaflavins by two volunteers.  Although quantities will vary from tea to tea depending 265 
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mainly upon the tea leaves and the degree to which they were fermented, based on the data of Del 266 
Rio et al.3 this is also equivalent to ~10 cups of tea. In the present study, after ingestion of a 1 g 267 
supplement containing 998 µmol of a mixture of theaflavins (Table 1), also equivalent to ~10 cups of 268 
tea, no theaflavins were detected in urine. The HPLC-HRMS limit of detection for theaflavin 269 
reference compounds was 0.3 ng. Taking into account that the urine samples were concentrated 270 
20-fold prior to analysis using Strata X solid phase extraction cartridges, total urinary theaflavin 271 
excretion 0-30 h after intake was <6 ng, representing <0.000001 % of intake. These results confirm, 272 
using much higher doses, the findings of Henning et al.34 who reported an absence of theaflavins in 273 
urine and prostate tissue from men who consumed six cups of black tea daily for a period of 3-8 274 
weeks.  275 
The evidence, therefore, indicates that black tea theaflavins have poor systemic bioavailability. 276 
During passage along the GI tract, substantial amounts will reach the colon where they will be 277 
subject to the action of the resident microbiota, potentially resulting in the formation of low 278 
molecular weight degradation products. In keeping with this possibility, after ingestion of the 279 
theaflavin extract in the current study, increased amounts of phenolic catabolites, 964 µmol, were 280 
detected in 0-30 h urine, corresponding to 94% of the 1014 µmol intake of polyphenols which was 281 
composed predominantly, of 988 µmol, of theaflavins (Table 3). However, it does not necessarily 282 
follow that this is the result of an extensive breakdown of the basic theaflavin ring structure. Most of 283 
the increased excretion of phenolics was due to enhanced quantities of hydroxybenzene derivatives, 284 
in particular 625 µmol of pyrogallol-1-sulfate 26 and pyrogallol-2-sulfate 27 (Table 3). These 285 
catabolites were probably derived from gallic acid 22 released by hydrolysis of the gallate moiety of 286 
the 811 µmol, of the ingested gallated theaflavins. The other phenolic compound to be excreted in a 287 
substantially increased amount after theaflavin consumption was the 166 µmol of 288 
3-(4'-hydroxyphenyl)propionic acid 10 (Table 3). This phenolic acid probably originated from 289 
theaflavin rather than gallic acid breakdown with much smaller amounts arising from ring fission of 290 
the 26 µmol of flavan-3-ol monomers and procyanidin dimer in the theaflavin extract. 291 
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A large number of phenolic catabolites have previously been identified following feeds20, 25, 292 
30-35, and in vitro fecal incubations with black tea.36,37 However as black tea contains numerous 293 
(poly)phenolics and related compounds,2 these studies unlike the current investigation, were unable 294 
to identify catabolites arising from theaflavins. 295 
Evidence for the stability of theaflavins in the lower gastrointestinal tract was obtained from 296 
the fecal incubations where the galloyl group was cleaved from theaflavin-3-O-gallate 6, 297 
theaflavin-3’-O-gallate 7 and theaflavin-3,3’-O-digallate 8. The released theaflavin skeleton 5 was 298 
relatively resistant to degradation with a 67% overall recovery of the theaflavins. This greatly 299 
exceeds the recoveries of flavan-3-ol monomers, flavanones and other dietary (poly)phenols when 300 
they are subjected to fecal incubations.25,26,38  301 
A total of 60 nmol of SREMs were excreted in urine. These would originate from the 3.4 µmol 302 
of flavanol monomers in the theaflavin extract (Table 1) while the 1437 nmol excretion of 5C-RFMs 303 
are also likely to be derived from the monomers and to some degree the procyanidin dimer, 304 
combined intake of which was 26 µmol. This represents a 5.7% conversion. 305 
There is a report of an increase in urinary excretion of hippuric acid 37 after black tea 306 
consumption by habitual tea drinkers.35 However, this increase is unlikely to be a consequence of 307 
microbial degradation of theaflavins, as no increase in the urinary excretion of hippuric acid was 308 
observed in the present study following ingestion of theaflavins in an amount equivalent to ~10 309 
cups of black tea. The 9.4 µmol increase in urinary excretion of 3′-hydroxyhippuric acid 29 and 310 
4′-hydroxyhippuric acid 30 could to some degree be associated with theaflavin 5 degradation 311 
although a very minor portion of the increase in 3′-hydroxyhippuric acid could be related to 312 
flavan-3-ol monomer and procyanidin breakdown28,29. 313 
The principle routes for the limited degradation of theaflavins may involve the proposed 314 
pathways, illustrated in Figure 4. The fecal incubations reveal that microbial enzymes result in the 315 
release of substantial amounts of gallic acid 22 from the galloylated-theaflavins. In vivo some of the 316 
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gallic acid 22 then appears to be converted to 3-O-methygallic acid 20 and 4-O-methygallic acid 21 317 
by mammalian enzymes while most is decarboxylated, probably by bacterial enzymes, to form 318 
pyrogallol 25 which undergoes phase II metabolism yielding substantial amounts of 319 
pyrogallol-1-sulfate 26 and pyrogallol-2-sulfate 27 and smaller amounts of a 320 
pyrogallol-2-O-glucuronide 28 (Table 3, Figure 4). The fecal incubations indicate that gallic acid 22 321 
can also be dehydroxylated yielding in turn 3,4-dihydroxybenzoic acid 16 and 3-hydroxybenzoic 322 
acid 17 (Table 5) with the latter potentially being glycinated in vivo by hepatic enzymes to form 323 
3′-hydroxyhippuric acid 29. 324 
Urinary excretion suggests that the limited degradation of theaflavin 5 appears to be linked to a 325 
plethora of minor products the major component of which is 3-(4′-hydroxyphenyl)propionic acid 10. 326 
Its formation would appear to involve mammalian as well as bacterial enzymes as it was not produced 327 
by the fecal incubates although small amounts of 3-(3′,4′-dihydroxyphenyl)propionic acid 32 did 328 
accumulate (Table 5). Potentially, further metabolism of 3-(4′-hydroxyphenyl)propionic acid 10 could 329 
involve side chain shortening via β-oxidation producing 4-hydroxybenzoic acid 18, a substrate for 330 
possible glycination in the liver to form 4′-hydroxyhippuric acid 30 (Figure 4). The, no doubt, complex 331 
array of pathways leading from theaflavin 5 to trace levels of the array of other phenolic catabolites, 332 
such as 3′-hydroxyphenylacetic acid 13, 4′-hydroxyphenylacetic acid 14 and 333 
3′-methoxy-4′-hydroxymandelic acid 38 (Table 3), is very much a matter of speculation and their 334 
elucidation represents a major analytical task.  Some clarification could be achieved by carrying out 335 
separate fecal incubations with gallic acid 22 and non-galloylated theaflavins 5. 336 
The data obtained in the present study suggest that beneficial effects associated with 337 
theaflavins arising from consumption of black tea would, most likely, be derived from their 338 
circulating metabolites/catabolites which are mainly of microbial origin. Two of the microbial 339 
bioconversion products, 3,4-dihydroxybenzoic acid 16 and phloroglucinol 23, along with their phase 340 
II sulfate and glucuronide metabolites, have been reported to reduce the levels of pro-inflammatory 341 
chemokines and adhesion molecules, such as IL-6 and sVCAM-1, in CD40L and oxidized 342 
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LDL-challenged vascular endothelial cells,39 TNF-α secretion in THP-1 monocytes at physiologically 343 
relevant concentrations,40 and sVCAM-1 secretion by human umbilical vein endothelial cells.41 It has 344 
also been reported that 3-(4´-hydroxyphenyl)propionic acid 10 and gallic acid 22, two key 345 
theaflavin-derived colonic catabolites, are able to protect neuronal cells from oxidative stress 346 
working as active agents against the onset and progress of neurodegenerative diseases.42  Gallic 347 
acid 22 also has protective effects on multiple parameters involved in atherosclerosis, including 348 
inflammation, cell adhesion, chemotaxis, endothelial function, estrogenic/antiestrogenic activity and 349 
angiotensin-converting enzyme inhibitory activity43 and on the inhibition of cell proliferation and 350 
induction of apoptosis in human colon cancer cells.44 Furthermore, 3-O-methylgallic acid 20 and 351 
4-O-methygallic acid 21, two biomarkers of theaflavin intake, have been reported to exert protective 352 
effects in vitro, at physiological concentrations. 3-O-Methylgallic acid 20 has been shown to cause a 353 
time- and dose-dependent decrease in cell viability, cell cycle arrest at G0/G1 and to stimulate the 354 
apoptotic pathway by the activation of caspase-3 in human colon cancer cells, thereby acting as 355 
anticancer agent,44 while 4-O-methylgallic acid 21 exhibited anti-inflammatory properties playing a 356 
role in the prevention of atherosclerotic processes45 and the treatment of endotoxemia.46 In addition, 357 
pyrogallol 25 has been reported to counteract key features of diabetes in vitro.47 358 
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FIGURE CAPTIONS 
 
Figure 1. Structures 1-9. 
 
Figure 2. Structures 10-38. 
 
Figure 3. Theaflavin 5, theaflavin-3-O-gallate 6, theaflavin-3´-O-gallate 7) and 
theaflavin3,3´-digallate 8 profiles of fecal fermentation samples from three volunteers over a 24 h of 
incubation. Data expressed as µmol, Standard error <5% of the mean in all instances (n = 3). 
 
Figure 4. Proposed principle pathways for the catabolism of theaflavins by colonic microbiota and 
mammalian phase II metabolism. Red arrows indicate microbiota-mediated steps and blue arrows 
represent mammalian enzyme-mediated conversions. The illustrated theaflavin is 
theaflavin-3-O-gallate 6. It assumed that the 3’-gallate 7 and the 3,3′-digallate 8 will be similarly 
Page 22 of 35
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
  
 
23 
subject to degalloylation releasing theaflavin. Boxed names indicate the main products to accumulate in 
urine after theaflavin intake. 
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Table 1. Quantities of Individual Polyphenols in 1 g of Theaflavin Extract.a  
Compound Amount (µmol) 
% in the 
theaflavin extract 
Theaflavin 5 177  17.4 
Theaflavin-3-O-gallate 6 307  30.4 
Theaflavin-3´-O-gallate 7 172  17.0 
Theaflavin-3,3´-O-digallate 8 332  32.8 
(–)-Epicatechin 1 0.13  0.01 
(+)-Gallocatechin-3-O-gallate 2 0.79  0.08 
(–)-Epigallocatechin-3-O-gallate 3 1.1  0.10 
(–)-Epicatechin-3-O-gallate 4 1.4  0.13 
Procyanidin dimer B2-3-O-gallate 9 22.7  2.26 
Total polyphenol intake 1014  
a Standard error < 5% in all instances (n =3) 
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Table 2. Quantities of Structurally-Related (−)-Epicatechin Metabolites (SREMs) and Five- 
Carbon Side Chain Ring Fission Metabolites (5C-RFMs) Excreted in Urine 0-30 h After the 
Consumption of 1 g of a Theaflavin Extract by Two Volunteers.a  
Metabolites (number of isomers) Total 0-30 h excretion 
SREMs  
(−)-Epicatechin-sulfate (2)  6.6 ± 3.1 
(−)-Epicatechin-O-glucuronide 0.9 ± 0.2 
O-Methyl-(−)-epicatechin-sulfate (3) 9.8 ± 2.5 
O-Methyl-(–)-epicatechin-O-glucuronide 43 ± 8 
Total SREMs 60 ± 15 
5C-RFMs 
5-(4',5'-Dihydroxyphenyl)-γ-valerolactone-3'-sulfate 84 ± 3 
5-(3',5'-Dihydroxyphenyl)-γ-valerolactone-4'-sulfate 256 ± 103 
5-(4',5'-Dihydroxyphenyl)-γ-valerolactone-3'-O-glucuronide 77 ± 17 
Total 5-(dihydroxyphenyl)-γ-valerolactones 417 ± 123 
  
5-(4'-Hydroxyphenyl)-γ-valerolactone-3´-sulfate  158 ± 113 
5-(3'-Hydroxyphenyl)-γ-valerolactone-4´-sulfate  37 ± 26 
5-(Hydroxyphenyl)-γ-valerolactone-O-glucuronide  12 ± 4 
Total 5-(hydroxyphenyl)-γ-valerolactones 208 ± 143 
  
5-(Phenyl)-γ-valerolactone-3´-sulfate 1.7 ± 0.5 
Total 5-(phenyl)-γ-valerolactones 1.7 ± 0.5 
  
5-(3',4'-Dihydroxyphenyl)-γ-hydroxyvaleric acid 101 ± 26 
5-(Dihydroxyphenyl)-γ-hydroxyvaleric acid-sulfate  393 ± 50 
5-(Dihydroxyphenyl)-γ-hydroxyvaleric acid-O-glucuronides (2) 167 ± 36 
Total 5-(dihydroxyphenyl)-γ-hydroxyvaleric acids 661± 112 
 
5-(3'-Hydroxyphenyl)-γ-hydroxyvaleric acid-3'-sulfate  14 ± 6 
5-(4'-Hydroxyphenyl)-γ-hydroxyvaleric acid-4'-sulfate  55 ± 19 
5-(4’-Hydroxyphenyl)-γ-hydroxyvaleric acid-3´-O-glucuronide  37 ± 14 
5-(3′-Hydroxyphenyl)-γ-hydroxyvaleric acid-4´-O-glucuronide  12 ± 3 
Total 5-(hydroxyphenyl)-γ-hydroxyvaleric acids 118 ± 43 
 
5-(Phenyl)-γ-hydroxyvaleric acid-sulfate  7.2 ± 6.4 
5-(Phenyl)-γ-hydroxyvaleric acid-O-glucuronide  24 ± 7 
Total 5-(phenyl)-γ-hydroxyvaleric acids 31 ± 14 
 
Total SREMS 60 ± 15 (1.7%) 
Total valerolactones and valeric acids 1437 ± 436 (5.6%) 
 
  Total metabolites 1495 ± 458 (5.7%) 
aData expressed as mean values in nmol ± SE (n = 2). Figure in italicised parentheses 
represents recovery as a percentage of intake of flavan-3-ol monomers (3.42 µmol) and 
procyanidin dimer (22.7 µmol).
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Table 3. Quantities of Phenolic Catabolites Excreted in Urine 0-30 h After the 
Consumption of 1 g of a Theaflavin Extract by Two Volunteersa. 
Phenolic catabolites (number of isomers) 
Total 0-30 h 
excretion 
Phenylpropanoic acid derivatives  
Caffeic acid-3´-sulfate 0.05 ± 0.05 
Ferulic acid 0.11 ± 0.07 
Isoferulic acid 0.7 ± 0.1 
Ferulic acid-4´-O-glucuronide 1.0 ± 0.6 
Ferulic acid-4´-sulfate 0.9 ± 0.7 
Total 2.8 ± 1.8 
Phenylpropionic acid derivatives  
3-(3´,4´-Dihydroxyphenyl)propionic acid 32 0.02 ± 0.02 
3-(4´-Hydroxyphenyl)propionic acid-3´-O-glucuronide 0.04 ± 0.01 
3-(3´-Hydroxyphenyl)propionic acid-4´-sulfate 0.25 ± 0.19 
3-(4´-Hydroxyphenyl)propionic acid-3´-sulfate 0.05 ± 0.01 
3-(3´-Methoxyphenyl)propionic acid-4´-O-glucuronide 0.11 ± 0.06 
3-(3´-Methoxyphenyl)propionic acid-4´-sulfate 0.10 ± 0.00 
3-(4'-Hydroxyphenyl)propionic acid 10 166 ± 91* 
3-(Phenyl)propionic acid-4´-sulfate  0.05 ± 0.04 
Total 166 ± 92 
Phenylacetic acid derivatives  
3´,4´-Dihydroxyphenylacetic acid 11 0.38 ± 0.15* 
3´-Methoxy-4´-hydroxyphenylacetic acid 12  1.2 ± 0.2* 
3′-Methoxyphenylacetic acid-4´-sulfate 0.15 ± 0.10 
4’-Methoxyphenylacetic acid-3´-sulfate 0.17 ± 0.15 
Methoxyphenylacetic acid-O-glucuronide 0.04 ± 0.00 
3´-Hydroxyphenylacetic acid 13 4.9 ± 0.6* 
4´-Hydroxyphenylacetic acid 14 6 ± 2* 
Phenylacetic acid 15 1.3 ± 1.3* 
Total 14.1 ± 4.4* 
Benzoic acid derivatives  
3,4-Dihydroxybenzoic acid 16 0.62 ± 0.28* 
3-Hydroxybenzoic acid-4-sulfate 0.33 ± 0.16 
4-Hydroxybenzoic acid-3-sulfate  0.02 ± 0.02 
3-Hydroxybenzoic acid 17 0.43 ± 0.33* 
4-Hydroxybenzoic acid 18 0.6 ± 0.5* 
Benzoic acid-4-sulfate 19 3.0 ± 0.3* 
Benzoic acid-3-sulfate 0.01± 0.01 
3-O-Methylgallic acid 20 10 ± 4* 
4-O-Methylgallic acid 21 27 ± 11* 
Gallic acid 22 2.3 ± 2.2* 
Total 45 ± 19* 
Hydroxycarboxylic acid derivatives  
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4′-Hydroxymandelic acid 1.6 ± 0.9 
3’-Methoxy-4’-hydroxymandelic acid 38 3.8 ± 1.6 
Total 5.4 ± 2.5 
Hydroxybenzene derivatives  
Phloroglucinol (1,3,5-trihydroxybenzene) 23 2.7 ± 2.0* 
Catechol (1,2-dihydroxybenzene) 24 6.9 ± 2.3* 
Pyrogallol (1,2,3-trihydroxybenzene) 25 73 ± 43* 
Pyrogallol-1-sulfate 26  134 ± 50* 
Pyrogallol-2-sulfate 27  491 ± 158* 
Pyrogallol-2-O-glucuronide 28  14.8 ± 4.7* 
  
Total 723 ± 260* 
Benzoyl glycine derivatives  
3'-Hydroxyhippuric acid 29 2.1 ± 0.4* 
4'-Hydroxyhippuric acid 30 7.3 ± 2.2* 
Total 9.4 ± 2.6* 
  
Significant increases in phenolic and aromatic catabolites 
955 ± 376* 
(94%)a 
aData corrected by subtraction of the 0-30 h baseline excretion levels and expressed as 
mean values in µmol ± SE (n = 2). Figure in italicised parentheses represents recovery 
as a percentage of 1014 μmol intake of polyphenols 
*Significant higher excretion above baseline (p<0.05, Wilcoxon signed-rank test test) 
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Table 4. Total Quantities of Compounds Recovered After a 24 h In Vitro Incubation of a Theaflavin Extract 
with Fecal Samples from Three Donors.a   
Compound Donor 1 (nmol) % Donor 2(nmol) %  Donor 3(nmol) %  
Theaflavins 7500  75 6700 67 6000 60 
Flavan-3-ol monomers 12  36.4 11 33.3 28 84.4 
 
5C-RFMs 
17.6  6.7 25.2  9.7 104 40 
Phenolic catabolites 1623  17 2530  25 100  0.1 
aData are expressed in nmol and as percentage of the initial substrate from which they were derived 
Percentage recoveries based on addition to incubates of 10000 nmol of theaflavins, 33 nmol of flavan-3-ol 
monomers, 5C-RFMs to 260 nmol of flavan-3-ol monomers and procyanidin dimer, and phenolic catabolites 
to the 10000 nmol of theaflavins.   
 
Page 28 of 35
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
Table 5. Quantities of Compounds In Medium After 0, 1, 2, 4, 8 and 24 h Incubation of a Theaflavin Extract With Feces 
From Three Donors.a  
Substrates 
Amount (µmol) 
Donor 0 h 1 h 2 h 4 h 6 h 8 h 24 h 
Theaflavin 5 
1 1.9 2.1  2.2  2.5 3.4 3.3  6.0 
2 1.9 2.5  2.4  2.3 3.0  5.1 6.7 
3 1.9 1.9  1.8  1.9 1.8 1.8 2.1 
Theaflavin-3-O-gallate 6 
1 4.4 4.0 4.0 3.4  3.5 3.2 1.5 
2 4.2 3.0  3.3 3.4  2.5 1.9 - 
3 4.4 4.7 4.3  3.9  2.9 2.7 2.3 
Theaflavin-3´-O-gallate 7 
1 1.5 1.4 1.4 1.0 1.0 0.8 - 
2 1.5 1.6 0.9  0.9 0.7 0.5 - 
3 1.5 1.6 1.4  1.3 0.9 0.9 0.8 
Theaflavin-3,3´-O-digallate 8 
1 2.5 2.4 2.2 1.8 1.3 1.2 - 
2 2.4 2.0 1.2 0.8  0.9  0.4 - 
3 2.5 2.1 12 1.7 1.0 0.8  0.8  
  Amount (nmol) 
Flavan-3-ol monomers* 
1 260 130 130 98 41 43 12 
2 260 154 110 87 86 72 11  
3 260 128 104 63 60 63  28  
5C-RFMs   
5-(3´,4´-Dihydroxyphenyl)-γ-valerolactone 35  
1 - - 0.07  0.09  0.06  0.1 0.1 
2 - - 0.9  1.4  1.3 1.7  1.9 
3 - 0.3  0.7 1.2  1.4 1.7  2.3  
5-(3´-Hydroxyphenyl)-γ-valerolactone 36  
1 - - - - - - - 
2 - - - - - - - 
3 - - - - 12 11 6  
5-(3´-Hydroxyphenyl)-γ-hydroxyvaleric acid 33  
1 - - - - 1.0 0.7 6.5 
2 - - 1.6 12 8 11 16 
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a Data expressed as mean values (n = 3). Standard error <15% of mean values. Structurally-related (−)-epicatechin 
metabolites, SREMs; 5C-side chain ring fission metabolites, 5C-RFMs; 3 carbon side chain ring fission metabolite, 3C-RFM; 
1-C side chain ring fission metabolites, 1C-RFMs 
3 - - 6.7 63 149 128  63  
5-(Phenyl)-γ-hydroxyvaleric acid 34  
1 - - 1.2  6.5  6.1  6.7 11 
2 - - 3.0  5.3  5.0  5.2 7.3 
3 - 4 6 22 27 29  33 
3C-RFM         
3-(3´,4´-Dihydroxyphenyl)propionic acid 32 
1 - - 50  43 49 - - 
2 - - - - - 100 - 
3 - - - 90 120 200  - 
1C-RFMs         
Gallic acid 22  
1 - 20 80 80  50 49 - 
2 - 40 90 140 230 170 - 
3 - - - 30 39 43 - 
3,4-Dihydroxybenzoic acid 16 
1 - - 51 - - - - 
2 - - 60 51 58 19 - 
3 - - - - 10 10 - 
3-Hydroxybenzoic acid 17 
1 - - - 498 603 931 - 
2  - - 290 480 320 - 
3 - - - - - - - 
Benzoic acid 31 
1 - - - - - 198  723 
2 - - 1100 1050 1120 1240 982 
3 - - - 1230 380  1060 - 
Trihydroxybenzene         
Pyrogallol 25 
1 - - 90 420 530 220 900 
2 - - - 70 180 1190 1548 
3 - - - - - - 100 
Page 30 of 35
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
HO
HO
O
OH
O O
HO OH
OH
OH
OH
(–)-Epigallocatechin-3-O-gallate 4
HO
HO
O
OH
O O
HO OH
OH
(–)-Epicatechin-3-O-gallate 3
HO
HO
O
OH
OH
(–)-Epicatechin 1
OH
OH
HO
OH
O
O
O
OH
OH
O
OH
OH
OH
HO
Theaflavin-3-O-gallate 6
HO
OH
O
OH
O
O
OH
O
OH
OH
OH
HO
Theaflavin-3'-O-gallate 7
OHHO
OH
O
HO
OH
O
O
O
O
OH
O
OH
OH
OH
HO
Theaflavin-3,3'-O-digallate 8
OHHO
OH
O
HO
OH
OH
O
HO
OH
OH
O
HO
HO
O
OH
HO
HO
O
OH
OH
Proanthocyanidin dimer B2 dimer-3'-O-gallate 9
OH
OH
HO
HO
O
OH
O O
HO OH
OH
(+)-Gallocatechin-3-O-gallate 2
OH
HO
OH
O
OH
O
OH
OH
O
OH
OH
OH
HO
Theaflavin 5
O
HO
OH
OH
O
OH
Page 31 of 35
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
HOOC
3-(4'-Hydroxyphenyl)propionic acid 10
OH
Gallic acid 22
OH
HOOC OH
OH
Pyrogallol 25
OH
OH
OH H
NHOOC
O
3'-Hydroxyhippuric acid 29
OH
H
NHOOC
O
OH
4'-Hydroxyhippuric acid 30
3,4-Dihydroxybenzoic acid 16
OH
HOOC
OH
HOOC
3-(3,4'-Dihydroxyphenyl)propionic acid 32
OH
OH
Pyrogallol-1-sulfate 26
OSO3
-
OH
OH
Pyrogallol-2-sulfate 27
OH
OH
OSO3
-
OH
OH
O
O
OH
OH
COOH
HO
Pyrogallol-2-O-glucuronide 28
HOOC
3',4'-Dihydroxyphenylacetic acid 11
OH
OH
HOOC
3'-Methoxy-4'-hydroxyphenylacetic acid 12
OH
OCH3
HOOC
3'-Hydroxyphenylacetic acid 13
OH
HOOC
4'-Hydroxyphenylacetic acid 14
OH
HOOC
Phenylacetic acid 15 3-Hydroxybenzoic acid 17
OH
HOOC
4-Hydroxybenzoic acid 18
HOOC
OH
Benzoic acid-4-sulfate 19
HOOC
OSO3
-
3-O-Methylgallic acid 20
OCH3
HOOC OH
OH
4-O-Methylgallic acid 21
OH
HOOC OH
OCH3
Phloroglucinol 23
OH
OHHO
Catechol 24
OH
OH
Benzoic acid 31
HOOC
OH
HOOC
 5-(3'-Hydroxyphenyl)-γ-hydroxyvaleric acid 33
OH
HOOC
 5-(Phenyl)-γ-hydroxyvaleric acid 34
OH
OH
OH
 5-(3',4'-Dihydroxyphenyl)-γ-valerolactone 35
O
O
OH
 5-(3'-Hydroxyphenyl)-γ-valerolactone 36
O
O
H
NHOOC
O
Hippuric acid 37 3'-Methoxy-4'-hydroxymandelic acid 38
OH
HOOC
OH
OCH3
Page 32 of 35
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B 
C 
A 
Theaflavin 5 
Theaflavin-3-O-gallate 6 
Theaflavin-3´-O-gallate 7 
Theaflavin-3,3´-O-digallate 8 
Page 33 of 35
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
HO
OH
O
O
O
OH
OH
O
OH
OH
OH
HO
Theaflavin-3-O-gallate
HO
OH
OH
O
HOOC
3-(4'-Hydroxyphenyl)propionic acid
OH
Gallic acid
OH
HOOC OH
OH
Pyrogallol
OH
OH
OH
4-O-Methylgallic acid
OH
HOOC OH
OCH3
3-O-Methylgallic acid
OCH3
HOOC OH
OH
HOOC
4'-Hydroxybenzoic acid
OH
H
NHOOC
O
3'-Hydroxyhippuric acid
OH
H
NHOOC
O
OH
4'-Hydroxyhippuric acid
3,4-Dihydroxybenzoic acid
OH
HOOC
OH
3-Hydroxybenzoic acid
OH
HOOC
HO
OH
O
OH
O
OH
OH
O
OH
OH
OH
HO
Theaflavin
HOOC
3-(3,4'-Dihydroxyphenyl)propionic acid
OH
OH
Pyrogallol-1-sulfate
OSO3
-
OH
OH
Pyrogallol-2-sulfate
OH
OH
OSO3
-
OH
OH
O
O
OH
OH
COOH
HO
Pyrogallol-2-O-glucuronide
Page 34 of 35
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
	Page 35 of 35
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
